Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005688 220002228 null 69.8 Curative (C) 2014-11-19 2014-12-09 AML17 TRIAL N N 220028736 AML17 TRIAL
220005689 220002228 0 80 null 2016-12-20 2016-12-20 Cytarabine Low Dose null N 220028736 CYTARABINE
220005690 220002228 null null Palliative (P) 2013-08-26 2013-09-23 Cytarabine Low Dose N N 220028736 CYTARABINE
220005691 220002228 null 65 Palliative (P) 2016-07-14 2016-07-14 CYTARABINE 02 null 220028736 CYTARABINE
220005692 220002228 null null null 2017-06-13 2017-06-13 Cytarabine low (10to20mg/m2) IV/SC N N 220028736 CYTARABINE
220005693 220002228 null 70 Curative (C) 2013-04-29 2013-05-01 AML17 TRIAL 01 N 220028736 AML17 TRIAL
220005694 220002228 1.63 0 Neo-adjuvant (N) 2014-02-21 2014-03-02 Cytarabine Low Dose N null 220028736 CYTARABINE
220005697 220002230 1.66 0 Curative (C) 2016-12-13 2016-12-13 Trial Unspecified 1 N 220028761 TRIAL
220005698 220002230 1.69 78.8 Not known (9) 2017-02-11 2017-02-15 AML17 TRIAL N N 220028761 AML17 TRIAL
220005699 220002231 1.68 57.8 Curative (C) 2016-03-12 2016-03-12 AML17 TRIAL 01 N 220028764 AML17 TRIAL
220005700 220002232 1.68 67.2 Not known (9) 2014-09-23 2014-10-13 AML17 TRIAL N N 220028768 AML17 TRIAL
220005701 220002232 1.88 82.3 Not known (9) 2016-05-11 2016-05-13 AML17 TRIAL N N 220028768 AML17 TRIAL
220005702 220002233 1.62 null Curative (C) 2015-03-25 2015-03-25 AML17 TRIAL Y N 220028771 AML17 TRIAL
220005703 220002233 null 77.5 Curative (C) null 2013-07-19 AML17 TRIAL N N 220028771 AML17 TRIAL
220005704 220002234 1.71 null Palliative (P) 2016-10-07 2016-10-07 Cytarabine low (10to20mg/m2) IV/SC N N 220028776 CYTARABINE
220005705 220002234 1.8 null Curative (C) 2013-09-18 2013-09-18 AML17 TRIAL 1 N 220028776 AML17 TRIAL
220005706 220002234 1.8 0 null 2014-12-01 2014-12-02 Trial Unspecified Y N 220028776 TRIAL
220005707 220002235 1.82 89.25 Curative (C) 2017-04-24 2017-04-24 Trial Unspecified 01 null 220028781 TRIAL
220005708 220011228 null 97.9 null 2017-10-23 2017-10-23 Trial Unspecified 01 null 220028782 TRIAL
220005709 220011228 null 73.4 Curative (C) 2014-01-25 2014-01-25 Trial Unspecified 1 null 220028782 TRIAL
220005710 220011228 null 86.8 Curative (C) 2014-06-19 2014-06-20 Trial Unspecified 01 N 220028782 TRIAL
220005711 220011228 1.66 55 Curative (C) 2014-10-20 2014-11-03 Trial Unspecified null N 220028782 TRIAL
220005713 220002237 1.75 60 Curative (C) 2017-04-17 2017-04-24 AML17 TRIAL N N 220028792 AML17 TRIAL
220005714 220011229 0 null Curative (C) 2013-11-23 2013-11-27 Trial Unspecified 01 N 220028794 TRIAL
220005715 220011229 null 60.5 Curative (C) 2016-03-09 2016-03-09 Trial Unspecified Y N 220028794 TRIAL
220005716 220011229 null null Curative (C) 2016-02-14 2016-02-18 Nilotinib 02 N 220028794 NILOTINIB
220005717 220002238 null null Palliative (P) 2013-01-22 2013-01-22 Nilotinib 2 N 220028801 NILOTINIB
220005718 220011230 1.52 0 Disease modification (D) 2015-04-07 2015-04-07 Nilotinib N N 220028802 NILOTINIB
220005719 220002239 1.71 80.3 Curative (C) 2013-06-16 2013-06-16 AML 19 TRIAL Y N 220028803 AML19 TRIAL
220005720 220002239 1.78 81 Adjuvant (A) 2016-11-30 2016-12-01 FLAG + Idarubicin N N 220028803 FLAG + IDARUBICIN
220005721 220016017 1.78 85 null 2017-08-12 2017-08-18 FLAG + Idarubicin N N 220028807 FLAG + IDARUBICIN
220005722 220016017 1.7 83.5 Not known (9) 2017-05-16 2017-05-17 Nilotinib N N 220028807 NILOTINIB
220005723 220016017 1.63 101.4 Curative (C) 2016-09-29 2016-09-29 FLAG + Idarubicin 99 N 220028807 FLAG + IDARUBICIN
220005724 220002240 null null Curative (C) 2018-05-26 2018-05-30 Nilotinib N N 220028815 NILOTINIB
220005725 220011232 1.66 77 Neo-adjuvant (N) 2015-07-07 2015-07-08 AML 19 TRIAL Y N 220028822 AML19 TRIAL
220005726 220002241 1.6 null Curative (C) 2014-09-13 2014-09-20 FLAG + Idarubicin 2 N 220028823 FLAG + IDARUBICIN
220005727 220002241 1.7 85.6 Curative (C) 2017-01-15 2017-01-15 FLAG + Idarubicin null null 220028823 FLAG + IDARUBICIN
220005728 220002241 1.75 65 Curative (C) 2015-07-12 2015-07-12 AML 19 TRIAL 1 N 220028823 AML19 TRIAL
220005729 220002241 1.71 null Curative (C) 2013-01-13 2013-01-13 null N N 220028823 NOT MATCHED
220005730 220002241 1.87 0 null 2018-01-02 2018-02-01 Nilotinib N N 220028823 NILOTINIB
220005731 220002242 1.69 87.2 Curative (C) 2016-06-09 2016-06-10 AML 19 TRIAL Y N 220028837 AML19 TRIAL
220005732 220002242 1.61 76.7 Curative (C) 2016-06-04 2016-06-04 Nilotinib N N 220028837 NILOTINIB
220005733 220002243 0 60.25 Curative (C) 2014-02-06 2014-02-07 NB HRNBL-1 COJEC Ind COURSE A N N 220028840 NOT MATCHED
220005734 220002243 null null Curative (C) 2015-10-28 2015-10-31 Nilotinib 2 N 220028840 NILOTINIB
220005735 220002243 0 0 Curative (C) 2013-11-18 2013-11-18 Nilotinib N N 220028840 NILOTINIB
220005736 220002243 1.71 83.2 Curative (C) 2015-05-18 2015-05-18 AML 19 TRIAL Y N 220028840 AML19 TRIAL
220005737 220002243 1.66 63.2 Curative (C) 2016-03-31 2016-04-01 AML 19 TRIAL Y N 220028840 AML19 TRIAL
220005738 220002243 0 55.9 Curative (C) 2015-03-09 2015-03-24 Nilotinib N N 220028840 NILOTINIB
220005739 220002243 1.74 null Disease modification (D) 2016-04-15 2016-04-15 Nilotinib N N 220028840 NILOTINIB
220005740 220002244 1.7 74 Curative (C) 2014-12-27 2014-12-27 AML 19 TRIAL 01 null 220028859 AML19 TRIAL